Crosswinds Holdings Inc Stock Toronto S.E.
Equities
CA2276961018
Biotechnology & Medical Research
Sales 2021 | - | Sales 2022 | - | Capitalization | 27.36M 37.63M |
---|---|---|---|---|---|
Net income 2021 | -4M -5.5M | Net income 2022 | -2M -2.75M | EV / Sales 2021 | - |
Net cash position 2021 | 2.23 3.06 | Net cash position 2022 | 0.02 0.02 | EV / Sales 2022 | - |
P/E ratio 2021 |
-17.8
x | P/E ratio 2022 |
-9.17
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 60.21% |
1st Jan change | Capi. | |
---|---|---|
-1.82% | 41.35B | |
+42.44% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |